Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - Part 3: Update on 5-year survival

被引:170
作者
Riall, TS
Cameron, JL
Lillemoe, KD
Campbell, KA
Sauter, PK
Coleman, J
Abrams, RA
Laheru, D
Hruban, RH
Yeo, CJ
机构
[1] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Med Inst, Sol Goldman Pancreas Canc Res Ctr, Baltimore, MD 21205 USA
[5] Indiana Univ, Dept Surg, Indianapolis, IN 46204 USA
[6] Rush Univ, Sch Med, Dept Radiat Oncol, Chicago, IL 60612 USA
关键词
pancreaticoduodenectomy; periampullary adenocarcinoma; pancreatic adenocarcinoma; ampullary adenocarcinoma; resection;
D O I
10.1016/j.gassur.2005.08.034
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The study objective was to update the survival analysis at the 55-year mark of patients undergoing standard versus radical (extended) pancreaticoduodenectomy (PD) for perianipullary adenocarcinoma (cancers of the pancreas, arripulla, common bile duct, and duodenum). A prospective randomized trial was performed (April 1996 through June 2001) comparing survival after pylorus-preserving PD resection (standard) to survival after PD with distal gastrectomy and retroperitoneal lymphadenectomy (radical). An interim report (Ann Surg 1999;229:613) and report after closing the trial (Ann Surg, 2002;236:355) showed no differences in survival between the standard and radical groups. Two hundred ninety-nine patients were randomized to either the standard or radical group. Five patients were excluded from final analysis because final pathology failed to reveal adenocarcinoma. The 5-year survival of the two groups was evaluated. The median live patient follow-up is now 64 months (5.33 years). For all periampullary cancer patients, those undergoing standard resection had 1- and 5-year survival rates of 78% and 25%, respectively, compared with 76% and 31% (P = 0.57) for those patients in the radical group. For pancreatic a adenocarcinoma patients, the 1- and 5-year survival rates in die standard group were 75% and 13%, respectively, compared with 73% and 29% in the radical group (P = 0.13). The increased morbidity rate, longer operative time, and similar survival for radical PD led us to conclude that pylorus-preserving PD without retroperitoneal lymphadenectomy should be the procedure of choice for most patients with resectable periampullary adenocarcinoma. While there is an intriguing trend toward improved survival in patients with pancreatic adenocarcinoma in the radical group, this trend may be largely accounted for by the higher incidence of microscopically margin positive resections in the standard resection group (2 1 %) compared with a 5 % incidence in the radical group (P = 0.002).
引用
收藏
页码:1191 / 1204
页数:14
相关论文
共 35 条
[1]  
Allison DC, 1998, J SURG ONCOL, V67, P151, DOI 10.1002/(SICI)1096-9098(199803)67:3<151::AID-JSO2>3.0.CO
[2]  
2-8
[3]  
[Anonymous], HPB
[4]   Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[5]   Long-term survival after curative resection for pancreatic ductal adenocarcinoma - Clinicopathologic analysis of 5-year survivors [J].
Conlon, KC ;
Klimstra, DS ;
Brennan, MF .
ANNALS OF SURGERY, 1996, 223 (03) :273-279
[6]   Patient survival after D1 and D2 resections for gastric cancer:: long-term results of the MRC randomized surgical trial [J].
Cuschieri, A ;
Weeden, S ;
Fielding, J ;
Bancewicz, J ;
Craven, J ;
Joypaul, V ;
Sydes, M ;
Fayers, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1522-1530
[7]   Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection [J].
Delcore, R ;
Rodriguez, FJ ;
Forster, J ;
Hermreck, AS ;
Thomas, JH .
AMERICAN JOURNAL OF SURGERY, 1996, 172 (05) :463-469
[8]   RANDOMIZED COMPARISON OF R1 AND R2-GASTRECTOMY FOR GASTRIC-CARCINOMA [J].
DENT, DM ;
MADDEN, MV ;
PRICE, SK .
BRITISH JOURNAL OF SURGERY, 1988, 75 (02) :110-112
[9]  
FORTNER JG, 1973, SURGERY, V73, P307
[10]   Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy [J].
Fortner, JG ;
Klimstra, DS ;
Senie, RT ;
Maclean, BJ .
ANNALS OF SURGERY, 1996, 223 (02) :147-153